DE2256838A1 - Wasserloesliches immunologisches adjuvans - Google Patents

Wasserloesliches immunologisches adjuvans

Info

Publication number
DE2256838A1
DE2256838A1 DE2256838A DE2256838A DE2256838A1 DE 2256838 A1 DE2256838 A1 DE 2256838A1 DE 2256838 A DE2256838 A DE 2256838A DE 2256838 A DE2256838 A DE 2256838A DE 2256838 A1 DE2256838 A1 DE 2256838A1
Authority
DE
Germany
Prior art keywords
substance
adjuvant
acid
cells
lipoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2256838A
Other languages
German (de)
English (en)
Inventor
Arlette Adam
Louis Chedid
Edgar Lederer
Jean Pierre Petit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7141610A external-priority patent/FR2160326B1/fr
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of DE2256838A1 publication Critical patent/DE2256838A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE2256838A 1971-11-19 1972-11-20 Wasserloesliches immunologisches adjuvans Withdrawn DE2256838A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7141610A FR2160326B1 (da) 1971-11-19 1971-11-19
FR7222120A FR2189019A2 (en) 1971-11-19 1972-06-19 Water-soluble immunological adjuvant - consisting of an oligomer of microbial cell wall components

Publications (1)

Publication Number Publication Date
DE2256838A1 true DE2256838A1 (de) 1973-05-24

Family

ID=26216727

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2256838A Withdrawn DE2256838A1 (de) 1971-11-19 1972-11-20 Wasserloesliches immunologisches adjuvans

Country Status (8)

Country Link
BE (1) BE791472A (da)
CA (1) CA1009972A (da)
CH (1) CH587346A5 (da)
DE (1) DE2256838A1 (da)
FR (1) FR2189019A2 (da)
LU (1) LU66491A1 (da)
NL (1) NL7215627A (da)
OA (1) OA04926A (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2450355A1 (de) * 1973-10-23 1975-05-28 Anvar Aus n-acyl-muraminsaeurederivaten gebildete adjuvanzien und diese enthaltende impfstoffe
FR2682599A1 (fr) * 1991-10-16 1993-04-23 Debat Lab Procede pour l'obtention d'extraits parietaux de nocardia, purifies et non pyrogenes, utiles notamment comme reactifs de diagnostic en imagerie medicale.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2450355A1 (de) * 1973-10-23 1975-05-28 Anvar Aus n-acyl-muraminsaeurederivaten gebildete adjuvanzien und diese enthaltende impfstoffe
FR2682599A1 (fr) * 1991-10-16 1993-04-23 Debat Lab Procede pour l'obtention d'extraits parietaux de nocardia, purifies et non pyrogenes, utiles notamment comme reactifs de diagnostic en imagerie medicale.

Also Published As

Publication number Publication date
FR2189019B2 (da) 1976-01-16
CA1009972A (en) 1977-05-10
FR2189019A2 (en) 1974-01-25
OA04926A (fr) 1980-10-31
NL7215627A (da) 1973-05-22
CH587346A5 (da) 1977-04-29
LU66491A1 (da) 1973-06-08
BE791472A (fr) 1973-05-16

Similar Documents

Publication Publication Date Title
DE2638762A1 (de) Wasserloesliche adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE69724970T2 (de) Verfahren zur behandlung von hypersensitivität typ i unter verwendung von monophosphoryl-lipid a
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DE2751717A1 (de) Neue verbesserte gammaglobuline fuer intravenoese injektion und verfahren zu ihrer herstellung
DE2606118A1 (de) Gamma-globuline fuer intravenoese injektion und verfahren zur herstellung von solchem gamma-globulin
DE2747379A1 (de) P-amino-phenyl-n-acetyl-muramyl-l- alanyl-d-isoglutamin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
DE3407823A1 (de) Lipopolysaccharid und verfahren zu seiner herstellung
DE2457090C2 (de) Verfahren zur Herstellung von Impfstoffen sowie Antibronchialimpfstoff
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
DE2519938A1 (de) Extrakte von corynebakterien, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen
DE2325299A1 (de) Aus mikroorganismen von der art der mycobakterien erhaltene, nicht-spezifische reizmittel, die eine antitumorimmunitaet hervorrufen und verfahren zu deren herstellung
DE3024282A1 (de) Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen
DE2518474A1 (de) Mitogenes mittel, verfahren zu seiner herstellung und diese mittel enthaltende arzneimittel und biologische reagenzien
AT408445B (de) Neue attenuierte pseudomonas aeruginosa-stämme
DE2823750C3 (de) Verfahren zur Gewinnung mindestens eines Hydrolyseprodukts eines Endotoxins von Bordetella Pertussis
DD202623A5 (de) Verfahren zur herstellung von sporen-polyosiden
EP0082890B1 (de) Verfahren zur Herstellung von immunbiologischen Präparaten, geeignet für den Nachweis von, die Vorbeugung gegen und/oder die Behandlung von Infektionen durch Candida guilliermondii
DE3850257T2 (de) Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen.
DE2256838A1 (de) Wasserloesliches immunologisches adjuvans
DE3029111C2 (da)
DE3207019A1 (de) Biologisch wirksame proteinverbindung, verfahren zu ihrer herstellung und mittel, enthaltend die verbindung
DE2851629A1 (de) Biologisches peptolidpraeparat, verfahren zu seiner herstellung und dieses praeparat enthaltende arzneimittel
DE2713680A1 (de) Verfahren zur herstellung eines mittels mit mitogenen und/oder adjuvans-eigenschaften und dieses mittel enthaltende arzneimittel
CH639667A5 (de) Verfahren zur herstellung von peptidkomplexen aus dns-haltigen organismen.
DE2710457A1 (de) 2-(2-acetamido-2-desoxy-3-0-d-glucopyranosyl)-d-propionyl-l-seryl-isoglutamin, 2-(2-acetamido-2-desoxy-3-0- d-glucopyranosyl)-d-propionyl-l-seryl- d-glutaminsaeure, die amid- und ester- derivate dieser verbindungen, verfahren zu ihrer herstellung und diese verbindungen als wirkstoffe enthaltende arzneimittel

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee